If upcoming clinical trials prove it’s safe for adult sickle cell patients to ingest tranylcypromine, the anti-depressant could be an alternative to the current treatment. © JJAVA - Fotolia.com by Katti Gray, theGrio After more than three decades of studying life-threatening sickle cell disease, the most prevalent of all hereditary illnesses, University of Michigan Medical School resear...
by Dr. Alecia Nero, BlackDoctor.org Transition of care from pediatric to adult medicine has b...
© 2011 Milwaukee Community Journal. All Rights Reserved
News by MCJ